Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment
- PMID: 10358758
- DOI: 10.1146/annurev.immunol.17.1.221
Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment
Abstract
Apoptosis of mature T lymphocytes preserves peripheral homeostasis and tolerance by countering the profound changes in the number and types of T cells stimulated by diverse antigens. T cell apoptosis occurs in at least two major forms: antigen-driven and lymphokine withdrawal. These forms of death are controlled in response to local levels of IL-2 and antigen in a feedback mechanism termed propriocidal regulation. Active antigen-driven death is mediated by the expression of death cytokines such as FasL and TNF. These death cytokines engage specific receptors that assemble caspase-activating protein complexes. These signaling complexes tightly regulate cell death but are vulnerable to inherited defects. Passive lymphokine withdrawal death may result from the cytoplasmic activation of caspases that is regulated by mitochondria and the Bcl-2 protein. The human disease, Autoimmune Lymphoproliferative Syndrome (ALPS) is due to dominant-interfering mutations in the Fas/APO-1/CD95 receptor and other components of the death pathway. The study of ALPS patients reveals the necessity of apoptosis for preventing autoimmunity and allows the genetic investigation of apoptosis in humans. Immunological, cellular, and molecular evidence indicates that throughout the life of a T cell, apoptosis may be evoked in excessive, harmful, or useless clonotypes to preserve a healthy and balanced immune system.
Similar articles
-
The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.Nat Immunol. 2000 Dec;1(6):469-74. doi: 10.1038/82712. Nat Immunol. 2000. PMID: 11101867 Review.
-
Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.Clin Immunol. 1999 Oct;93(1):34-45. doi: 10.1006/clim.1999.4767. Clin Immunol. 1999. PMID: 10497009
-
Cell cycle regulation by FasL and Apo2L/TRAIL in human T-cell blasts. Implications for autoimmune lymphoproliferative syndromes.J Leukoc Biol. 2008 Aug;84(2):488-98. doi: 10.1189/jlb.0108043. Epub 2008 May 15. J Leukoc Biol. 2008. PMID: 18483205
-
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.Cell. 1999 Jul 9;98(1):47-58. doi: 10.1016/S0092-8674(00)80605-4. Cell. 1999. PMID: 10412980
-
Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.J Hum Genet. 1998;43(1):2-8. doi: 10.1007/s100380050029. J Hum Genet. 1998. PMID: 9609991 Review.
Cited by
-
Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells.Sci Transl Med. 2015 Jun 10;7(291):291ra94. doi: 10.1126/scitranslmed.aaa5447. Sci Transl Med. 2015. PMID: 26062846 Free PMC article.
-
Fas ligand triggers pulmonary silicosis.J Exp Med. 2001 Jul 16;194(2):155-64. doi: 10.1084/jem.194.2.155. J Exp Med. 2001. PMID: 11457890 Free PMC article.
-
p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling.J Clin Invest. 2002 Jun;109(11):1481-92. doi: 10.1172/JCI14967. J Clin Invest. 2002. PMID: 12045262 Free PMC article.
-
P27kip1 regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawal.Immunology. 2003 Apr;108(4):493-501. doi: 10.1046/j.1365-2567.2003.01605.x. Immunology. 2003. PMID: 12667211 Free PMC article.
-
Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen.J Exp Med. 2001 Sep 17;194(6):707-17. doi: 10.1084/jem.194.6.707. J Exp Med. 2001. PMID: 11560988 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
